Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calender
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calender
    • Contact
  • Molecular Med Tri-Conference
 
  • Multianalyte Liquid Biopsy Detects Early-Stage Breast Cancer

    Diagnostics World News | Robust levels of large extracellular vesicles (LEVs) were found “hiding in plain sight” in the blood of early-stage breast cancer patients in a recent study led by a team of scientists at the University of Southern California. The LEVs are roughly the size of a cell and found while using a high-definition liquid biopsy platform to stratify normal donors from those with early- or late-stage breast cancer.

    Nov 1, 2022
  • Ultrahuman Launches Glucose Monitoring Health Platform, Automated Cancer Tracking Tool Measures Tumor Dynamics, More

    Diagnostics World News | Clinical whole exome sequencing services identify possible disease-causing genetic changes; a composite biomarker system uses multiple clinically relevant patient features to reflect the heterogeneity of graft failure; a regulatory science tool improves the review processes for stroke rehabilitation devices; and more.

    Oct 27, 2022
  • Follow the Money: National Consortium for Lewy Body Dementia Diagnostics, Wearable Vest System Detects Worsening Heart Conditions, More

    Diagnostics World News | Funding for biomarker analysis for patients with nonalcoholic fatty liver disease, improving early diagnosis and survival rates of patients with nasopharyngeal cancer, genome sequencing analysis of the Epstein-Barr virus, and more.

    Oct 26, 2022
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67 (current)
  • 68
  • 69
  • 70
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy